KYO-1Homo sapiens (Human)Cancer cell line

Also known as: Kyoto 1, KYO1

🤖 AI SummaryBased on 7 publications

Quick Overview

KYO-1 is a Ph' chromosome-positive cell line derived from CML in blast crisis, used for studying differentiation and proliferat...

Detailed Summary

KYO-1 is a Ph' chromosome-positive cell line established from the peripheral blood of a patient with chronic myelogenous leukemia (CML) in blastic crisis. This cell line exhibits the unique capacity to differentiate along the erythroid and monocytic lineages for the first several months, although this capability gradually diminishes with repeated passages. KYO-1 cells are considered undifferentiated myeloid cells and provide a valuable model for studying the differentiation and proliferation of pluripotent stem cells from CML in blastic crisis. The cell line has been maintained in continuous culture for over three years with a doubling time of approximately 22 hours. KYO-1 retains colony-forming ability in agar cultures, with a significant proportion of colonies containing α-NBE positive cells, indicating some degree of differentiation potential.

Research Applications

Study of differentiation and proliferation of pluripotent stem cellsInvestigation of erythroid and monocytic differentiationAnalysis of Ph' chromosome-positive CML cell lines

Key Characteristics

Ph' chromosome-positiveUndifferentiated myeloid cellsSpontaneous differentiation along erythroid and monocytic lineages for initial passagesContinuous culture for over three yearsColony-forming ability in agar cultures
Generated on 6/18/2025

Basic Information

Database IDCVCL_2095
SpeciesHomo sapiens (Human)
Tissue SourcePeripheral blood[UBERON:UBERON_0000178]

Donor Information

Age22
Age CategoryAdult
SexMale
Raceasian
Subtype FeaturesBCR-ABL1 positive

Disease Information

DiseaseChronic myeloid leukemia
LineageMyeloid
SubtypeChronic Myeloid Leukemia, BCR-ABL1+
OncoTree CodeCMLBCRABL1

DepMap Information

Source TypeDSMZ
Source IDACH-000604_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Arg248Gln (c.743G>A)UnspecifiedSomatic mutation acquired during proliferationPubMed=20575032
Gene fusionABL1BCR-ABL1, BCR-ABL-BCR exon 1 fused to ABL1 exon 2PubMed=10576511, PubMed=10071072, PubMed=8751477

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11,14
D13S317
12
D16S539
10
D18S51
14
D19S433
14,16
D21S11
30
D2S1338
24
D3S1358
16,18
D5S818
10,13
D7S820
11
D8S1179
12,14
FGA
18,25
Penta D
10,11
Penta E
11,15,17
TH01
6,7
TPOX
9,11
vWA
14
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Screening human cell lines for viral infections applying RNA-Seq data analysis.

Uphoff C.C., Pommerenke C., Denkmann S.A., Drexler H.G.

PLoS ONE 14:E0210404-E0210404(2019).

Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.

Yang H.H., Koeffler H.P.

BMC Cancer 18:940.1-940.13(2018).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

ABL-BCR expression in BCR-ABL-positive human leukemia cell lines.";

Uphoff C.C., Habig S., Fombonne S., Matsuo Y., Drexler H.G.

Leuk. Res. 23:1055-1060(1999).

Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.

Drexler H.G., MacLeod R.A.F., Uphoff C.C.

Leuk. Res. 23:207-215(1999).

A novel Ph1 chromosome positive cell line established from a patient with chronic myelogenous leukemia in blastic crisis.

Ohkubo T., Kamamoto T., Kita K., Hiraoka A., Yoshida Y., Uchino H.

Leuk. Res. 9:921-926(1985).

Ph positive CML cell lines.";

Keating A.

Baillieres Clin. Haematol. 1:1021-1029(1987).

The leukemia-lymphoma cell line factsbook.";

Drexler H.G.

(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).